1OWEN R G,TREON S P,AL-KATIB A,et al.Clinicopathological definition of Waldenstrom's macroglobulinemia:consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia[J].Semin Oncol,2003,30:110-115.
2TREON S P,GERTZ M A,DIMOPOULOS M,et al.Update on treatment recommendations from the Third International Workshop on Waldenstrom's macroglobulinemia[J].Blood,2006,107:3442-3446.
3LELEU X,SOUMERAI J,ROCCARO A,et al.Inereased inadence of trarsformation and mylodysplasiy acute leukemia in patierts with waldersrom macrylobulmemia treated with nudeoside aralogs[J].J Clin Oncol,2009,27:250-255.
4TREON S P,HUNTER Z R,MATOUS J,et al.Multicenter clinical trial of bortezomib in relapsed/refractory Waldenstrom's macroglobulinemia:results of WMCTG Trial 03-248[J].Clin Cancer Res,2007,13:3320-3325.
5CHEN C I,KOUROUKIS C T,WHITE D,et al.Bortezomib is active in patients with untreated or relapsed Waldenstrom's macro-globulinemia:a phase II study of the National CancerInstitute of Canada Clinical Trials Group[J].J Clin Oncol,2007,25:1570-1575.
